Europa Biosite introduces rapid RNA production technologies
Europa Biosite (Täby, Sweden) has announced a new strategic distribution partnership with Quantoom Biosciences (Nivelles, Belgium), a manufacturer of mRNA technologies for global healthcare advancement, supporting next-generation vaccines and therapeutics. The agreement provides access to Quantoom’s pioneering research RNA production solutions for scientists across Europe.
Under the partnership, Europa Biosite will distribute Quantoom’s Ntensify® mano and Ntensify® micro technology, designed for rapid and qualitative RNA production in research settings. The collaboration is expected to broaden to include Ncapsulate® LNP formulation kits as these technologies become available to the research market.
Europa Biosite is recognized for building high-quality supplier relationships and delivering advanced reagents and technologies to academic, biotech and pharmaceutical laboratories through its pan-European distribution network. The addition of Quantoom’s RNA production portfolio strengthens Europa Biosite’s offering in the rapidly expanding RNA research field.
José Castillo, CEO of Quantoom Biosciences commented: “Europa Biosite has built an impressive reputation for connecting innovative technologies with leading research laboratories across Europe.” He added, “by joining forces, we make high-quality RNA production and formulation tools more accessible, helping researchers accelerate the development of next-generation RNA applications.”
Together, the companies aim to equip researchers with RNA production and formulation technologies that reduce technical barriers and accelerate progress in RNA research and therapeutic development.
For further information please contact AMSBIO directly.
About AMSBIO
AMSBIO, part of the Europa Biosite group, is a leading life sciences company supporting drug discovery, translational research and cell and gene therapy across Europe, North America and wider international markets. With in depth expertise in advanced cell culture, 3D cell models and cryopreservation, AMSBIO is well placed to help researchers progress from early discovery through to clinical and GMP-ready applications. The company’s portfolio of innovative products and services supports multiple stages of the research pipeline, spanning target discovery, assay development and disease modeling, through to stem cell and organoid-based research. Key solutions include the integrated stem cell platform combining StemFit™ media, iMatrix™ recombinant laminins and CELLBANKER™ cryopreservation technology, alongside extracellular matrix technologies, biospecimens, glycobiology tools, kits and assays, and a wide range of custom services, including viral delivery. Drawing on extensive GMP expertise and a comprehensive human and animal biorepository, AMSBIO is internationally recognized for delivering high-quality, application-ready products and services. AMSBIO has a consistent record of close scientific collaboration with partners in academic, biotech and pharmaceutical markets to translate innovation from bench to bedside.
About Europa Biosite
Europa Biosite is a pan-European group of life science distributors providing researchers and biotechnology companies with access to a broad portfolio of research technologies and laboratory products. Through a coordinated network across Europe, the group combines central strategy with strong local expertise and established relationships within regional research communities. Backed by EQT Healthcare Growth, Europa Biosite continues to expand its European footprint through strategic acquisitions.
About Quantoom Biosciences
Quantoom Biosciences is a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics. Its N-Force toolbox relies on three core elements to turn any antigen into an (sa)mRNA-LNP drug product: Ncode for sequence design and optimization, Ntensify® for RNA production and Ncapsulate® for RNA-LNP formulation. Launched in 2023, the Ntensify solution enables fully integrated, scalable RNA production by combining processes, equipment, reagent mixes and disposables, and has gained global adoption, being recognized for performance and ease-of-use. Beyond technology, Quantoom Biosciences assists its partners by providing extensive enabling solutions, ranging from strategic R&D partnerships to sequence design and optimization. Quantoom Biosciences is a trade name of Phoenix Biosciences SA.